Name

NA

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for NA

Name

Alternate Names

14-hydroxy-daunomycin
Adri-blastina (Italy)
Adriamycin
Adriamycin-TM
Caelyx
FT-106
Hydroxydaunomycin
Myocet
Pegylated Liposomal Doxorubicin Hcl
Rubex
S-DOX
Stealth(R) Liposomal Doxorubicin

Abbreviations

ADM
ADR
ADRI

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

123127

Primary Site

Bladder
breast
liver
multiple myeloma
ovarian
pancreatic
prostate cancer

Histology

None

Remarks

Phase II liver, pancreatic, Phase III MM, prostate Doxorubicin hydrochloride encapsulated in liposomes formulated with methoxypolyethylene glycol (MPEG). FDA approved use on bladder cancer, breast cancer, gastric cancer, leukemia, small cell lung cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, thyroid cancer, Wilm's tumor. ALZA Corp, NeoPharm, Pharmacia, Schering-Plough, Sequus. Antitumor antibiotic

Coding

This drug should be coded

Name

Alternate Names

Navelbine
Navelbine ditartrate
Vinorelbine Ditartrate
Vinorelbine Tartrate

Abbreviations

VNB

Category

Chemotherapy

Subcategory

Plant alkyloid

NSC Number

608210

Primary Site

Breast
lung cancer

Histology

None

Remarks

Phase III NSCLC Vinca alkaloid; mitotic inhibitor. FDA approved use on NSCLC. GlaxoSmithKline.

Coding

This drug should be coded
Glossary